Expert Opinion on Biological Therapy, Volume 22, Issue 3 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Biological Therapy, Volume 22, Issue 3 (2022)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Volume 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Harmonizing PD-L1 testing in metastatic triple negative breast cancer
Federica Giugliano, Gabriele Antonarelli, Paolo Tarantino, Javier Cortes, Hope S. Rugo & Giuseppe Curigliano
Pages: 345-348
Published online: 29 Dec 2021
First Page PreviewforHarmonizing PD-L1 testing in metastatic triple negative breast cancer | Full Text | References | PDF (2.3 MB) | EPUB
  • 3841 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Review

Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review
Mina Hosseini, Zahra Habibi, Narges Hosseini, Sina Abdoli & Nima Rezaei
Pages: 349-366
Published online: 22 Oct 2021
AbstractforPreclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a review | Full Text | References | PDF (1.4 MB) | EPUB
  • 576 Views
  • 3 CrossRef citations
  • 0Altmetric
Tildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations
Marco Galluzzo, Andrea Chiricozzi, Elisa Cinotti, Giovanna Brunasso, Maurizio Congedo, Maria Esposito, Chiara Franchi, Giovanna Malara, Alessandra Narcisi, Stefano Piaserico, Rossana Tiberio, Giuseppe Argenziano, Gabriella Fabbrocini & Aurora Parodi
Pages: 367-376
Published online: 12 Oct 2021
AbstractforTildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations | Full Text | References | PDF (2.4 MB) | EPUB
  • 3474 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Reduction/elimination of blood eosinophils in severe asthma: should there be a safety consideration?
Konstantinos Katsoulis, Maria Kipourou & Stelios Loukides
Pages: 377-384
Published online: 10 Aug 2021
AbstractforReduction/elimination of blood eosinophils in severe asthma: should there be a safety consideration? | Full Text | References | PDF (1.9 MB) | EPUB
  • 420 Views
  • 2 CrossRef citations
  • 0Altmetric
Combination of HER2-targeted agents with immune checkpoint inhibitors in the treatment of HER2-positive breast cancer
Ashley Matusz-Fisher & Antoinette R. Tan
Pages: 385-395
Published online: 21 Nov 2021
AbstractforCombination of HER2-targeted agents with immune checkpoint inhibitors in the treatment of HER2-positive breast cancer | Full Text | References | PDF (323.5 KB) | EPUB
  • 369 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Treatment of fibrous dysplasia: focus on denosumab
Bogdan Huzum, Sabina Antoniu & Raluca Dragomir
Pages: 397-405
Published online: 29 Dec 2021
AbstractforTreatment of fibrous dysplasia: focus on denosumab | Full Text | References | PDF (337.2 KB) | EPUB
  • 553 Views
  • 1 CrossRef citations
  • 0Altmetric
Identifying and managing CAR T-cell–mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team
Massimo Martino, Sebastiano Macheda, Umberto Aguglia, Luciano Arcudi, Giulia Pucci, Bruno Martino, Maria Altomonte, Antonio Maria Rossetti, Giuseppa Cusumano, Letteria Russo, Lucrezia Imbalzano, Caterina Stelitano, Caterina Alati, Jessyca Germano’, Demetrio Labate, Vincenzo Amalfi, Maria Teresa Florenzano, Antonella Morabito, Vittoria Borzumati, Vincenzo Dattola, Caterina Gattuso, Antonio Moschella, Domenico Quattrone, Francesco Curmaci, Claudio Franzutti, Giuseppe Scappatura, Carmelo Massimiliano Rao, Viviana Loddo, Antonella Pontari, Maria Pellicano’, Rosangela Surace, Cristina Sanguedolce, Virginia Naso, Anna Ferreri, Giuseppe Irrera, Giuseppe Console, Tiziana Moscato, Barbara Loteta, Filippo Antonio Canale, Alfonso Trimarchi, Renza Monteleone, Said Al Sayyad, Frank Cirrone & Benedetto Bruno
Pages: 407-421
Published online: 15 Sep 2021
AbstractforIdentifying and managing CAR T-cell–mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team | Full Text | References | PDF (401.4 KB) | EPUB
  • 412 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Rotavirus vaccines: progress and new developments
Jordan E. Cates, Jacqueline E. Tate & Umesh Parashar
Pages: 423-432
Published online: 10 Sep 2021
AbstractforRotavirus vaccines: progress and new developments | Full Text | References | PDF (2.3 MB) | EPUB
  • 691 Views
  • 8 CrossRef citations
  • 0Altmetric
Current status of developing tissue engineering vascular technologies
Ryuma Iwaki, Toshihiro Shoji, Yuichi Matsuzaki, Anudari Ulziibayar & Toshiharu Shinoka
Pages: 433-440
Published online: 24 Aug 2021
AbstractforCurrent status of developing tissue engineering vascular technologies | Full Text | References | PDF (2.5 MB) | EPUB
  • 190 Views
  • 2 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Switching pattern of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network
Andrea Spini et al.
Article | Published online: 20 May 2024
Next generation CD40 agonists for cancer immunotherapy
Hampus Andersson et al.
Review Article | Published online: 20 May 2024
Open Access
Non-TNF biologics and their biosimilars in rheumatoid arthritis
Tsz Ching Mok et al.
Review Article | Published online: 20 May 2024
Relative bioavailability, immunogenicity, and safety of two adalimumab-adbm formulations in healthy volunteers: a double-blind, randomized, single-dose, parallel-arm Phase I trial (VOLTAIRE-HCLF)
Viktoria Moschetti et al.
Article | Published online: 19 May 2024
Open Access
View all latest articles